Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...

Canada lags behind other developed countries when it comes to the length of time it takes to approve desperately needed ...

INNOVATE Corp. (VATE) announced that the U.S. FDA has approved the MediBeacon TGFR for the assessment of kidney function in patients with normal ...

AND EARLIER THIS WEEK, THE FDA ANNOUNCED THE BAN OF RED DYE NUMBER THREE. THE CONTROVERSIAL INGREDIENT OFTEN FOUND IN DRINKS, CANDY AND CEREAL. I’M JOINED NOW BY DOCTOR TARA KESTER, AND INTEGRATED ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...

The U.S. Justice Department is accusing Walgreens of filling millions of prescriptions in the last decade and more without a ...

Gov. Katie Hobbs released her plan to fund state services for a year, including proposals on child care, private school ...

A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill ...

AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.

Sleep expert Dr. Abhay Sharma talks about how Zepbound is now approved by the FDA for the treatment of moderate to severe obstructive sleep apnea.

Arrowhead Pharmaceuticals said Friday that the Food and Drug Administration accepted the company's new drug application for its treatment of familial chylomicronemia syndrome, a severe and rare ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...